Skip to main content
. 2014 Sep 29;32(36):4042–4049. doi: 10.1200/JCO.2013.52.6780

Table 2.

Effects of MMA on Commonly Used Chemotherapy Drugs

graphic file with name zlj03614-4689-t02.jpg

Drug Typical Daily Dose Reimbursement ($)
Difference ($)
2004 2005
Leucovorin 48.00 20.77 −27.23
Bevacizumab 4,571.70 3,996.84 −574.86
Carboplatin injection 1,521.96 839.05 −682.91
Cetuximab 10,177.92 9,239.13 −938.79
Cisplatin 257.64 67.65 −189.99
Cyclophosphamide 71.82 15.82 −56.00
Docetaxel 2,109.80 2,068.81 −40.99
Etoposide 102.51 33.84 −68.68
Fluorouracil 38.85 29.30 −9.56
Gemcitabine 2,853.20 3,232.33 379.13
Irinotecan 4,172.82 4,302.11 129.29
Oxaliplatin 4,495.40 4,430.36 −65.04
Paclitaxel 1,244.52 134.55 −1,109.97
Pemetrexed 4,306.83 3,771.06 −535.77
Topotecan 2,824.68 2,994.61 169.93
Vinorelbine 685.71 476.90 −208.81
Doxorubicin 89.76 58.84 −30.92
Doxorubicin liposome 3,168.54 3,245.61 77.07
Trastuzumab 2,912.56 3,000.20 87.64
Ifosfomide 1,210.95 429.27 −781.68
Mitomycin 185.64 77.30 −108.34

NOTE. Dollar amounts are for a daily dose, not a full multiday regimen.

Abbreviation: MMA, Medicare Prescription Drug, Improvement, and Modernization Act of 2003.